Curriculum Vitae John Darmawan, MD, PhD.
Name : John Darmawan
Education :
Fellow, Rheumatology Unit, Department of Medicine,
The Royal Melbourne Hospital, University of Melbourne,
Melbourne, Australia PhD, Erasmus University Rotterdam,
Rotterdam, The Netherlands.
Current Appointments: :
- WHO Expert on the Rheumatic Diseases by direct
appointment of the Director General of The World
Health Organization, Geneva, Switzerland, and
The Minister of Health, Republic of Indonesia in
1992
with limited UN Immunity (1992-1996). Extended to
1996-2000, 2000-2003, and 2003-2007.
- WHO-ILAR COPCORD Coordinator for 2001-2005
- APLAR COPCORD Coordinator 1998-2004
- Chairman, APLAR SubComittee on Rheumatoid
Arthritis 1996-2004.
- Ankylosing SpondyloArthropathy Study group
(ASAS Member since 1993-)
- Member Editorial Board, Current Rheumatology
Reviews (CRR)
- International Fellow American College of
Rheumatology
- Honorary Member of APLAR.
Previous positions :
- Vice President of ILAR representing APLAR for
1992-1996
- President of APLAR 1992-1996.
- Secretary General of APLAR1988-1992.
- Chairman, APLAR Standing Committee on
Epidemiology 1992-1996
- Member Editorial Board, Lupus, an International
Journal
- Member Editorial Board, Current Opinion in
Rheumatology
- Member Editorial Board, Journal American Medical
Association, Southeast Asia.
- Director, WHO Collaborating Center,
Community-based Epidemiology, Prevention, and
Treatment of the Rheumatic, Indonesia Rheumatic
Center, Jakarta-Semarang, Indonesia, 1994-2004.
Publications :
over a hundred international and national Lay People,
Medical, and Rheumatology education, and Research
Papers in various local, national, and international
medical
and Rheumatology accredited journals.
Chapter: John Darmawan Disorders of Connective Tissue,
Bone and Joints. In: Chris J van Boxtel, Budiono
Santoso, I Ralph Edwards (eds) Drug Benefits and
Risks – International Text Book of Clinical Pharmacolog.
Wiley & Sons, LTD, Chichester.
Email This Page
Print
This Page
|
|
| |
NEWS & EVENTS
LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum
16.11.2005
MabThera – a unique approach providing lasting
benefits for patients with rheumatoid arthritis
Comprehensive long-term clinical success achieved in
difficult-to-treat patients following just two
administrations, two weeks apart
›
more
|
|
 |
| |
LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum
06.09.2005
Roche files first rheumatoid arthritis indication for
MabThera in Europe
MabThera: a medicine used to treat non-Hodgkin's
lymphoma
MabThera delivers significant and sustained relief from
symptoms in patients with difficult-to-treat rheumatoid
arthritis.
›
more
|
|
|
|
| |
LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum
06.04.2005
MabThera significantly improves symptoms in patients
with rheumatoid arthritis who inadequately responded to
anti-TNFα therapies
Third large randomised trial to evaluate efficacy and
safety of MabThera in RA
Roche, Genentech and Biogen Idec announced today that
REFLEX1, a pivotal Phase III study of MabThera (rituximab), successfully met its
primary endpoint in the group of patients with the most difficult-to-treat
rheumatoid arthritis (RA).
›
more
|
|
 |
Legal Disclamer
|
Legal Disclaimer
Copyright
©WHO-ILAR COPCORD Stage II Education on Treatment of the Autoimmune
Diseases.
This Web site was developed in 2005 as a service provided by the
WHO-ILAR COPCORD Stage II Education on Treatment of the Autoimmune
Diseases. This Web site provides selected information available
about lupus and arthritis. It is important that public see a
healthcare professional for detailed information about medical
conditions and treatment. This information is not intended to be a
substitute for the advice of a healthcare professional, or a
recommendation for any particular treatment plan. The WHO-ILAR
COPCORD Stage II Education on Treatment of the Autoimmune Diseases
has made and will continue to make efforts to include accurate and
up-to-date information on this Web site.
If you have any
questions, please contact us:
Webmaster
Phone: 62-24-8447-345
Fax: 62-24-8310-028
admin@LupusArthritisIndonesia.org
|
|
Bahasa 
